it`s the balance sheet stupid, page-100

Jeeps from the annoucement about 18 months ago:

Thirty minutes after application, TPM/diclofenac delivered on average over 400 percent more
diclofenac into the stratum corneum, than the commercial product, Voltaren? (p<0.001;
Figure 1). Phosphagenics? TPM/diclofenac also significantly augmented the depth of
penetration, with 380 percent (p<0.001) more diclofenac found in the deepest layers of the
skin sampled.

The trial clearly demonstrated that the TPM/diclofenac formulation had a quicker onset and
greater magnitude of diclofenac delivery than Voltaren?, with increased delivery maintained
for at least six hours, the duration of the trial.

If I was Novartis I'd be shitting myself if that got into a compeitors hands.